We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+21.03%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.53B
AUM Growth
+$291M
Cap. Flow
-$61.3M
Cap. Flow %
-2.42%
Top 10 Hldgs %
30.32%
Holding
118
New
3
Increased
36
Reduced
65
Closed
5

Top Buys

Rank Stock Value
1
EVR icon
Evercore
EVR
+$21.6M
2
APP icon
Applovin
APP
+$14M
3
IQV icon
IQVIA
IQV
+$13.8M
4
LDOS icon
Leidos
LDOS
+$9.19M
5
DHR icon
Danaher
DHR
+$7.22M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$16.9M
2
PEN icon
Penumbra
PEN
+$14.2M
3
SMCI icon
Super Micro Computer
SMCI
+$14M
4
VRT icon
Vertiv
VRT
+$12.5M
5
CELH icon
Celsius Holdings
CELH
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 29.91%
2 Financials 12.5%
3 Healthcare 12.35%
4 Consumer Discretionary 10.26%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
76
Vanguard S&P 500 ETF
VOO
$1.03T
$15.2M 0.6%
31,600
-2,916
-8% -$1.33M
IQV icon
77
IQVIA
IQV
$39.3B
$15M 0.59%
+59,141
New +$13.8M
AEE icon
78
Ameren
AEE
$30.1B
$14.8M 0.59%
200,062
+39,500
+25% +$2.81M
GPN icon
79
Global Payments
GPN
$22.8B
$14.3M 0.57%
106,895
-6,356
-6% -$840K
FDX icon
80
FedEx
FDX
$75.4B
$14.2M 0.56%
49,126
-9,237
-16% -$2.31M
AME icon
81
Ametek
AME
$58.2B
$12.7M 0.5%
69,212
-1,403
-2% -$242K
LIN icon
82
Linde
LIN
$226B
$11.7M 0.46%
25,228
-21
-0.1% -$9.09K
JAZZ icon
83
Jazz Pharmaceuticals
JAZZ
$16.7B
$11.4M 0.45%
94,289
-3,734
-4% -$457K
MET icon
84
MetLife
MET
$62.1B
$11.3M 0.45%
151,978
-14,000
-8% -$976K
DE icon
85
Deere & Co
DE
$168B
$9.93M 0.39%
24,183
-905
-4% -$347K
CMCSA icon
86
Comcast
CMCSA
$90B
$6.86M 0.27%
158,140
+3,203
+2% +$138K
LW icon
87
Lamb Weston
LW
$7.19B
$5.58M 0.22%
52,342
-25,604
-33% -$2.66M
MS icon
88
Morgan Stanley
MS
$340B
$5.28M 0.21%
56,088
-192,278
-77% -$16.9M
AZN icon
89
AstraZeneca
AZN
$250B
$4.59M 0.18%
33,914
-21,838
-39% -$2.89M
SPY icon
90
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$4.37M 0.17%
8,353
-113
-1% -$56.3K
TKO icon
91
TKO Group
TKO
$13.6B
$3.94M 0.16%
45,613
-76,142
-63% -$6.34M
KO icon
92
Coca-Cola
KO
$375B
$3.79M 0.15%
62,016
-790
-1% -$47.5K
VRRM icon
93
Verra Mobility
VRRM
$744M
$3.48M 0.14%
139,445
+8,545
+7% +$194K
EXE
94
Expand Energy Corp
EXE
$21.5B
$1.76M 0.07%
19,875
MCD icon
95
McDonald's
MCD
$195B
$1.62M 0.06%
5,750
-500
-8% -$145K
BAX icon
96
Baxter International
BAX
$14.2B
$1.61M 0.06%
37,700
-50
-0.1% -$2.03K
HON icon
97
Honeywell
HON
$78B
$1.6M 0.06%
8,249
MDY icon
98
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$1.28M 0.05%
2,307
-28
-1% -$14.5K
V icon
99
Visa
V
$677B
$1.17M 0.05%
4,200
DIS icon
100
Walt Disney
DIS
$181B
$624K 0.02%
5,101

Similar funds

Braun Stacey Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Braun Stacey Associates held 118 positions worth $2.53B, up 13% from $2.24B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Braun Stacey Associates's Q1 2024 filing shows 3 new, 36 increased, 65 reduced and 5 closed positions. Its largest new stake was Evercore: 119,578 shares worth $23M. The largest sale was Morgan Stanley, an estimated $16.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Braun Stacey Associates's largest Q1 2024 buy was Evercore: 119,578 shares worth $23M.
  • Braun Stacey Associates added most to Leidos in Q1 2024, an estimated $9.19M increase.
  • Braun Stacey Associates's biggest Q1 2024 reduction was Morgan Stanley, cutting an estimated $16.9M.
  • Braun Stacey Associates fully exited Penumbra in Q1 2024, selling an estimated $14.2M.
  • Braun Stacey Associates's ten largest holdings make up 30% of its $2.53B portfolio in Q1 2024.
  • Braun Stacey Associates opened 3 new positions and closed 5 in Q1 2024.
  • Braun Stacey Associates's portfolio value rose 13% quarter-over-quarter to $2.53B.

Based on Braun Stacey Associates's 13F filing for Q1 2024, filed 30 Apr 2024.